Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    23075176 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Treatment of Psychosis and Agitation in Alzheimer's Disease
Conditions: Alzheimer's Disease;   Psychosis;   Agitation
Interventions: Drug: Lithium;   Drug: Placebo
2 Completed
Has Results
Antipsychotic Discontinuation in Alzheimer's Disease
Conditions: Alzheimer Disease;   Psychotic Disorders;   Agitation;   Aggression
Intervention: Drug: risperidone

Indicates status has not been verified in more than two years